What's New on the FDA Drugs Site
October 25, 2016
- Public Notification: Zi Su Body Fat Health II (紫苏瘦身营养素 II – Zi Su Shou Shen Ying Yang Su II) Contains Hidden Drug Ingredient
- CDER Statement: FDA approves new changes to testosterone labeling regarding the risks associated with abuse and dependence of testosterone and other anabolic androgenic steroids (AAS)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Doxorubicin Lyophilized Powder for Injection (Updated - Currently in Shortage)
- Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment Guidance for Industry (PDF - 298KB)
- Manual of Policies and Procedures (MAPP) 5210.5 Rev.2 Review of Investigational New Drug Applications (Bio-INDs) by the Office of Generic Drugs (PDF - 126KB)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario